Search research articles
Contact Us
Filters
Showing results (271-280 of 311) with videos related to
Page
of 32
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
June 13, 2025
Radiosurgical management of SDHx-related paraganglioma
Paul M Harary, Yusuke S Hori, Aroosa Zamarud, et al.
Journal of Neurosurgery. Case Lessons
|
January 20, 2025
Coexisting sellar Rathke cleft cyst and planum sphenoidale meningioma: illustrative case
Amirhossein Akhavan-Sigari, David J Park, Paul M Harary, et al.
World Neurosurgery
|
August 28, 2020
Intracranial Tumor Control After Immune-Related Adverse Events and Discontinuation of Immunotherapy for Melanoma
Michael Zhang, Adrian J Rodrigues, Hriday P Bhambhvani, et al.
Journal of Neuro-Oncology
|
July 23, 2025
Stereotactic radiosurgery for intracranial and spinal adenoid cystic carcinoma: systematic review and illustrative case presentation
Juan J Cardona, David J Park, Mohamed F Al Gharyani, et al.
Journal of Neurosurgery. Spine
|
March 2, 2020
Local control and toxicity outcomes of stereotactic radiosurgery for spinal metastases of gastrointestinal origin
Navjot Sandhu, Kathryn R K Benson, Kiran A Kumar, et al.
Cureus
|
May 3, 2024
Dosimetric Comparison of Dedicated Radiosurgery Platforms for the Treatment of Essential Tremor: Technical Report
Neelan J Marianayagam, Ian Paddick, Amit R Persad, et al.
Practical Radiation Oncology
|
May 20, 2020
Stereotactic Radiosurgery for Resected Brain Metastases: Does the Surgical Corridor Need to be Targeted?
Siyu Shi, Navjot Sandhu, Michael Jin, et al.
Journal of Neuro-Oncology
|
January 14, 2026
Surgical resection versus stereotactic radiosurgery for succinate dehydrogenase-related hereditary head and neck paragangliomas
Paul M Harary, Yusuke S Hori, Fred C Lam, et al.
Neurosurgical Review
|
April 10, 2026
The impact of CHEK2 status on radiosurgical outcomes in breast cancer brain metastases
Paul M Harary, Yusuke S Hori, Ahed H Kattaa, et al.
Journal of Neuro-Oncology
|
January 8, 2021
Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases
Michael Zhang, Adrian J Rodrigues, Erqi L Pollom, et al.
Page
of 32
Search research articles
Search
Showing results (271-280 of 311) with videos related to
Sort By:
Page
of 32
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
June 13, 2025
Radiosurgical management of SDHx-related paraganglioma
Paul M Harary, Yusuke S Hori, Aroosa Zamarud, et al.
Journal of Neurosurgery. Case Lessons
|
January 20, 2025
Coexisting sellar Rathke cleft cyst and planum sphenoidale meningioma: illustrative case
Amirhossein Akhavan-Sigari, David J Park, Paul M Harary, et al.
World Neurosurgery
|
August 28, 2020
Intracranial Tumor Control After Immune-Related Adverse Events and Discontinuation of Immunotherapy for Melanoma
Michael Zhang, Adrian J Rodrigues, Hriday P Bhambhvani, et al.
Journal of Neuro-Oncology
|
July 23, 2025
Stereotactic radiosurgery for intracranial and spinal adenoid cystic carcinoma: systematic review and illustrative case presentation
Juan J Cardona, David J Park, Mohamed F Al Gharyani, et al.
Journal of Neurosurgery. Spine
|
March 2, 2020
Local control and toxicity outcomes of stereotactic radiosurgery for spinal metastases of gastrointestinal origin
Navjot Sandhu, Kathryn R K Benson, Kiran A Kumar, et al.
Cureus
|
May 3, 2024
Dosimetric Comparison of Dedicated Radiosurgery Platforms for the Treatment of Essential Tremor: Technical Report
Neelan J Marianayagam, Ian Paddick, Amit R Persad, et al.
Practical Radiation Oncology
|
May 20, 2020
Stereotactic Radiosurgery for Resected Brain Metastases: Does the Surgical Corridor Need to be Targeted?
Siyu Shi, Navjot Sandhu, Michael Jin, et al.
Journal of Neuro-Oncology
|
January 14, 2026
Surgical resection versus stereotactic radiosurgery for succinate dehydrogenase-related hereditary head and neck paragangliomas
Paul M Harary, Yusuke S Hori, Fred C Lam, et al.
Neurosurgical Review
|
April 10, 2026
The impact of CHEK2 status on radiosurgical outcomes in breast cancer brain metastases
Paul M Harary, Yusuke S Hori, Ahed H Kattaa, et al.
Journal of Neuro-Oncology
|
January 8, 2021
Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases
Michael Zhang, Adrian J Rodrigues, Erqi L Pollom, et al.
Page
of 32